ANNIE HUMPHREY: Open Payments
NPI 1427681535 · DANVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 8 companies in 2025. Trend: 2023 $312 · 2024 $426 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $65 |
| PFIZER INC. | 3 | $63 |
| Bausch Health US, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: APLENZIN, NURTEC ODT, Wegovy, Ozempic, INGREZZA, PREVNAR 20, EVKEEZA, LO LOESTRIN FE.
Industry payments across CA — which companies pay providers there.
